Oyster Point Pharma Inc

NASDAQ:OYST   12:28:05 PM EDT
20.33
+1.24 (+6.50%)
Products, Strategic Combinations

Oyster Point Pharma Announces Collaboration With Adaptive Phage Therapeutics

Published: 06/10/2021 11:44 GMT
Oyster Point Pharma Inc (OYST) - Oyster Point Pharma Announces Collaboration With Adaptive Phage Therapeutics (apt) to Target Ophthalmic Diseases.
Oyster Point - Co Has Option, Rights to Obtain Exclusive License to Develop, Commercialize Apt's Phagebank Technology for Ophthalmic Diseases.
Oyster Point - Under License Terms, If Such Option is Exercised, Co Has Agreed to Pay Apt Potential Development and Regulatory Milestones.
Oyster Point Pharma Inc - Apt Retains Production Rights to Phagebank and Will Supply Oyster Point Pharma Product at an Agreed Upon Cost-plus Model.